Global Intelligent Tissue Autonomous Robots 麻豆原创 Research Report 2023

Publication ID:

PB504230059

Publication Date:

June 1, 2023

Pages:

109

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Hardware (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

Intelligent Tissue Autonomous Robots are robotic devices that plan, adjust, and execute surgical plans in soft tissues without human assistance.
The global Intelligent Tissue Autonomous Robots market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Intelligent Tissue Autonomous Robots is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Intelligent Tissue Autonomous Robots is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Intelligent Tissue Autonomous Robots include Intuitive Surgical, Stryker Corporation, Medtronic, Veracyte, KARL STORZ, TransEnterix, Medrobotics Corporation, Corindus Vascular Robotics and Auris Health, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intelligent Tissue Autonomous Robots, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intelligent Tissue Autonomous Robots.
The Intelligent Tissue Autonomous Robots market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Intelligent Tissue Autonomous Robots market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intelligent Tissue Autonomous Robots manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Intuitive Surgical
Stryker Corporation
Medtronic
Veracyte
KARL STORZ
TransEnterix
Medrobotics Corporation
Corindus Vascular Robotics
Auris Health
Think Surgical
Titan Medical
Virtual lncision Corporation
XACT Robotics
Alpinion Medical Systems
Cian Health
Segment by Type
General Surgery
Gynecological Surgery
Urological Surgery
Colorectal Surgery
Cardiac Surgery
Others
Segment by Application
Hospitals
Research Institutes
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intelligent Tissue Autonomous Robots manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intelligent Tissue Autonomous Robots in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Intelligent Tissue Autonomous Robots 麻豆原创 Overview
1.1 Product Overview and Scope of Intelligent Tissue Autonomous Robots
1.2 Intelligent Tissue Autonomous Robots Segment by Type
1.2.1 Global Intelligent Tissue Autonomous Robots 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 General Surgery
1.2.3 Gynecological Surgery
1.2.4 Urological Surgery
1.2.5 Colorectal Surgery
1.2.6 Cardiac Surgery
1.2.7 Others
1.3 Intelligent Tissue Autonomous Robots Segment by Application
1.3.1 Global Intelligent Tissue Autonomous Robots 麻豆原创 Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Research Institutes
1.3.4 Others
1.4 Global Intelligent Tissue Autonomous Robots 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Intelligent Tissue Autonomous Robots Revenue 2018-2029
1.4.2 Global Intelligent Tissue Autonomous Robots Sales 2018-2029
1.4.3 Global Intelligent Tissue Autonomous Robots 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Intelligent Tissue Autonomous Robots 麻豆原创 Competition by Manufacturers
2.1 Global Intelligent Tissue Autonomous Robots Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Intelligent Tissue Autonomous Robots Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Intelligent Tissue Autonomous Robots Average Price by Manufacturers (2018-2023)
2.4 Global Intelligent Tissue Autonomous Robots Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intelligent Tissue Autonomous Robots, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intelligent Tissue Autonomous Robots, Product Type & Application
2.7 Intelligent Tissue Autonomous Robots 麻豆原创 Competitive Situation and Trends
2.7.1 Intelligent Tissue Autonomous Robots 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intelligent Tissue Autonomous Robots Players 麻豆原创 Share by Revenue
2.7.3 Global Intelligent Tissue Autonomous Robots 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intelligent Tissue Autonomous Robots Retrospective 麻豆原创 Scenario by Region
3.1 Global Intelligent Tissue Autonomous Robots 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intelligent Tissue Autonomous Robots Global Intelligent Tissue Autonomous Robots Sales by Region: 2018-2029
3.2.1 Global Intelligent Tissue Autonomous Robots Sales by Region: 2018-2023
3.2.2 Global Intelligent Tissue Autonomous Robots Sales by Region: 2024-2029
3.3 Global Intelligent Tissue Autonomous Robots Global Intelligent Tissue Autonomous Robots Revenue by Region: 2018-2029
3.3.1 Global Intelligent Tissue Autonomous Robots Revenue by Region: 2018-2023
3.3.2 Global Intelligent Tissue Autonomous Robots Revenue by Region: 2024-2029
3.4 North America Intelligent Tissue Autonomous Robots 麻豆原创 Facts & Figures by Country
3.4.1 North America Intelligent Tissue Autonomous Robots 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intelligent Tissue Autonomous Robots Sales by Country (2018-2029)
3.4.3 North America Intelligent Tissue Autonomous Robots Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intelligent Tissue Autonomous Robots 麻豆原创 Facts & Figures by Country
3.5.1 Europe Intelligent Tissue Autonomous Robots 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intelligent Tissue Autonomous Robots Sales by Country (2018-2029)
3.5.3 Europe Intelligent Tissue Autonomous Robots Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intelligent Tissue Autonomous Robots 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Intelligent Tissue Autonomous Robots 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intelligent Tissue Autonomous Robots Sales by Country (2018-2029)
3.6.3 Asia Pacific Intelligent Tissue Autonomous Robots Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intelligent Tissue Autonomous Robots 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Intelligent Tissue Autonomous Robots 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intelligent Tissue Autonomous Robots Sales by Country (2018-2029)
3.7.3 Latin America Intelligent Tissue Autonomous Robots Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intelligent Tissue Autonomous Robots 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Intelligent Tissue Autonomous Robots 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intelligent Tissue Autonomous Robots Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intelligent Tissue Autonomous Robots Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intelligent Tissue Autonomous Robots Sales by Type (2018-2029)
4.1.1 Global Intelligent Tissue Autonomous Robots Sales by Type (2018-2023)
4.1.2 Global Intelligent Tissue Autonomous Robots Sales by Type (2024-2029)
4.1.3 Global Intelligent Tissue Autonomous Robots Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Intelligent Tissue Autonomous Robots Revenue by Type (2018-2029)
4.2.1 Global Intelligent Tissue Autonomous Robots Revenue by Type (2018-2023)
4.2.2 Global Intelligent Tissue Autonomous Robots Revenue by Type (2024-2029)
4.2.3 Global Intelligent Tissue Autonomous Robots Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Intelligent Tissue Autonomous Robots Price by Type (2018-2029)
5 Segment by Application
5.1 Global Intelligent Tissue Autonomous Robots Sales by Application (2018-2029)
5.1.1 Global Intelligent Tissue Autonomous Robots Sales by Application (2018-2023)
5.1.2 Global Intelligent Tissue Autonomous Robots Sales by Application (2024-2029)
5.1.3 Global Intelligent Tissue Autonomous Robots Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Intelligent Tissue Autonomous Robots Revenue by Application (2018-2029)
5.2.1 Global Intelligent Tissue Autonomous Robots Revenue by Application (2018-2023)
5.2.2 Global Intelligent Tissue Autonomous Robots Revenue by Application (2024-2029)
5.2.3 Global Intelligent Tissue Autonomous Robots Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Intelligent Tissue Autonomous Robots Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Intuitive Surgical
6.1.1 Intuitive Surgical Corporation Information
6.1.2 Intuitive Surgical Description and Business Overview
6.1.3 Intuitive Surgical Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Intuitive Surgical Intelligent Tissue Autonomous Robots Product Portfolio
6.1.5 Intuitive Surgical Recent Developments/Updates
6.2 Stryker Corporation
6.2.1 Stryker Corporation Corporation Information
6.2.2 Stryker Corporation Description and Business Overview
6.2.3 Stryker Corporation Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Stryker Corporation Intelligent Tissue Autonomous Robots Product Portfolio
6.2.5 Stryker Corporation Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medtronic Intelligent Tissue Autonomous Robots Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Veracyte
6.4.1 Veracyte Corporation Information
6.4.2 Veracyte Description and Business Overview
6.4.3 Veracyte Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Veracyte Intelligent Tissue Autonomous Robots Product Portfolio
6.4.5 Veracyte Recent Developments/Updates
6.5 KARL STORZ
6.5.1 KARL STORZ Corporation Information
6.5.2 KARL STORZ Description and Business Overview
6.5.3 KARL STORZ Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.5.4 KARL STORZ Intelligent Tissue Autonomous Robots Product Portfolio
6.5.5 KARL STORZ Recent Developments/Updates
6.6 TransEnterix
6.6.1 TransEnterix Corporation Information
6.6.2 TransEnterix Description and Business Overview
6.6.3 TransEnterix Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.6.4 TransEnterix Intelligent Tissue Autonomous Robots Product Portfolio
6.6.5 TransEnterix Recent Developments/Updates
6.7 Medrobotics Corporation
6.6.1 Medrobotics Corporation Corporation Information
6.6.2 Medrobotics Corporation Description and Business Overview
6.6.3 Medrobotics Corporation Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Medrobotics Corporation Intelligent Tissue Autonomous Robots Product Portfolio
6.7.5 Medrobotics Corporation Recent Developments/Updates
6.8 Corindus Vascular Robotics
6.8.1 Corindus Vascular Robotics Corporation Information
6.8.2 Corindus Vascular Robotics Description and Business Overview
6.8.3 Corindus Vascular Robotics Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Corindus Vascular Robotics Intelligent Tissue Autonomous Robots Product Portfolio
6.8.5 Corindus Vascular Robotics Recent Developments/Updates
6.9 Auris Health
6.9.1 Auris Health Corporation Information
6.9.2 Auris Health Description and Business Overview
6.9.3 Auris Health Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Auris Health Intelligent Tissue Autonomous Robots Product Portfolio
6.9.5 Auris Health Recent Developments/Updates
6.10 Think Surgical
6.10.1 Think Surgical Corporation Information
6.10.2 Think Surgical Description and Business Overview
6.10.3 Think Surgical Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Think Surgical Intelligent Tissue Autonomous Robots Product Portfolio
6.10.5 Think Surgical Recent Developments/Updates
6.11 Titan Medical
6.11.1 Titan Medical Corporation Information
6.11.2 Titan Medical Intelligent Tissue Autonomous Robots Description and Business Overview
6.11.3 Titan Medical Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Titan Medical Intelligent Tissue Autonomous Robots Product Portfolio
6.11.5 Titan Medical Recent Developments/Updates
6.12 Virtual lncision Corporation
6.12.1 Virtual lncision Corporation Corporation Information
6.12.2 Virtual lncision Corporation Intelligent Tissue Autonomous Robots Description and Business Overview
6.12.3 Virtual lncision Corporation Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Virtual lncision Corporation Intelligent Tissue Autonomous Robots Product Portfolio
6.12.5 Virtual lncision Corporation Recent Developments/Updates
6.13 XACT Robotics
6.13.1 XACT Robotics Corporation Information
6.13.2 XACT Robotics Intelligent Tissue Autonomous Robots Description and Business Overview
6.13.3 XACT Robotics Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.13.4 XACT Robotics Intelligent Tissue Autonomous Robots Product Portfolio
6.13.5 XACT Robotics Recent Developments/Updates
6.14 Alpinion Medical Systems
6.14.1 Alpinion Medical Systems Corporation Information
6.14.2 Alpinion Medical Systems Intelligent Tissue Autonomous Robots Description and Business Overview
6.14.3 Alpinion Medical Systems Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Alpinion Medical Systems Intelligent Tissue Autonomous Robots Product Portfolio
6.14.5 Alpinion Medical Systems Recent Developments/Updates
6.15 Cian Health
6.15.1 Cian Health Corporation Information
6.15.2 Cian Health Intelligent Tissue Autonomous Robots Description and Business Overview
6.15.3 Cian Health Intelligent Tissue Autonomous Robots Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Cian Health Intelligent Tissue Autonomous Robots Product Portfolio
6.15.5 Cian Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intelligent Tissue Autonomous Robots Industry Chain Analysis
7.2 Intelligent Tissue Autonomous Robots Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intelligent Tissue Autonomous Robots Production Mode & Process
7.4 Intelligent Tissue Autonomous Robots Sales and 麻豆原创ing
7.4.1 Intelligent Tissue Autonomous Robots Sales Channels
7.4.2 Intelligent Tissue Autonomous Robots Distributors
7.5 Intelligent Tissue Autonomous Robots Customers
8 Intelligent Tissue Autonomous Robots 麻豆原创 Dynamics
8.1 Intelligent Tissue Autonomous Robots Industry Trends
8.2 Intelligent Tissue Autonomous Robots 麻豆原创 Drivers
8.3 Intelligent Tissue Autonomous Robots 麻豆原创 Challenges
8.4 Intelligent Tissue Autonomous Robots 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Intuitive Surgical
Stryker Corporation
Medtronic
Veracyte
KARL STORZ
TransEnterix
Medrobotics Corporation
Corindus Vascular Robotics
Auris Health
Think Surgical
Titan Medical
Virtual lncision Corporation
XACT Robotics
Alpinion Medical Systems
Cian Health

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.